Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 6:13:929736.
doi: 10.3389/fgene.2022.929736. eCollection 2022.

Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine

Affiliations
Review

Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine

Habiba Abdelhalim et al. Front Genet. .

Abstract

Precision medicine has greatly aided in improving health outcomes using earlier diagnosis and better prognosis for chronic diseases. It makes use of clinical data associated with the patient as well as their multi-omics/genomic data to reach a conclusion regarding how a physician should proceed with a specific treatment. Compared to the symptom-driven approach in medicine, precision medicine considers the critical fact that all patients do not react to the same treatment or medication in the same way. When considering the intersection of traditionally distinct arenas of medicine, that is, artificial intelligence, healthcare, clinical genomics, and pharmacogenomics-what ties them together is their impact on the development of precision medicine as a field and how they each contribute to patient-specific, rather than symptom-specific patient outcomes. This study discusses the impact and integration of these different fields in the scope of precision medicine and how they can be used in preventing and predicting acute or chronic diseases. Additionally, this study also discusses the advantages as well as the current challenges associated with artificial intelligence, healthcare, clinical genomics, and pharmacogenomics.

Keywords: artificial intelligence; clinical-genomics; healthcare; pharmacogenomics; precision medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Concept diagram of the artificial intelligence, clinical genomics, pharmacogenomics, and big data approaches in precision medicine.

References

    1. Ahmed Z., Zeeshan S., Xiong R., Liang B. T. (2019). Debutant iOS App and Gene-Disease Complexities in Clinical Genomics and Precision Medicine. Clin. Transl. Med. 8 (1), 26–11. 10.1186/s40169-019-0243-8 - DOI - PMC - PubMed
    1. Ahmed Z., Kim M., Liang B. T. (2019). MAV-clic: Management, Analysis, and Visualization of Clinical Data. JAMIA open 2 (1), 23–28. 10.1093/jamiaopen/ooy052 - DOI - PMC - PubMed
    1. Ahmed Z., Mohamed K., Zeeshan S., Dong X. (2020). Artificial Intelligence with Multi-Functional Machine Learning Platform Development for Better Healthcare and Precision Medicine. Database J. Biol. databases curation 2020, baaa010. 10.1093/database/baaa010 - DOI - PMC - PubMed
    1. Ahmed Z. (2020). Practicing Precision Medicine with Intelligently Integrative Clinical and Multi-Omics Data Analysis. Hum. Genomics 14 (1), 35. 10.1186/s40246-020-00287-z - DOI - PMC - PubMed
    1. Ahmed Z., Renart E. G., Mishra D., Zeeshan S. (2021). JWES: a New Pipeline for Whole Genome/exome Sequence Data Processing, Management, and Gene‐variant Discovery, Annotation, Prediction, and Genotyping. FEBS Open bio 11 (9), 2441–2452. 10.1002/2211-5463.13261 - DOI - PMC - PubMed

LinkOut - more resources